Digital Health Program for Post-COVID Syndrome

(LIGHT Trial)

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Rhode Island Hospital

Disqualifiers: Limited mental capacity, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

10 Participants Needed

Trial Summary

What is the purpose of this trial?

The current study seeks to pilot test the iENDURE (Enhancing Distress tolerance to Uplift motivation in Recovery) intervention among 10 participants with Long COVID (Coronavirus Disease) symptoms. Following informed consent procedures, participants will complete a brief baseline assessment of self-report measures. Participants will then engage in the iENDURE intervention (described below) for 4 weeks. At the end of the intervention period, participants will complete another brief assessment of self-report measures and a qualitative interview about their experience with the program. Participants will be compensated for completing the baseline and post-intervention assessments

Research Team

Kirsten Langdon, PhD

Principal Investigator

Brown University

Eligibility Criteria

This trial is for adults over 18 who have self-reported Long COVID symptoms and a past diagnosis of COVID-19. Participants must own a device capable of texting and speak English well enough to give informed consent.

Inclusion Criteria

Must own a text-enabled device

I have symptoms of Long-COVID.

I have been diagnosed with COVID-19.

Exclusion Criteria

I am not fluent in English.

I am unable to understand or sign the consent form due to mental capacity.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants engage in the iENDURE intervention for Long COVID symptoms

4 weeks

Weekly virtual sessions

Follow-up

Participants complete a post-intervention assessment and qualitative interview

1 week

Treatment Details

Interventions

• iENDURE

Trial Overview The iENDURE program, aimed at improving distress tolerance in individuals with Long COVID, is being tested. It involves a baseline assessment, a 4-week intervention period using digital health technology, followed by another assessment and interview.

Participant Groups

Group I: distress tolerance skills training Experimental Treatment 1 Intervention

technology delivered distress tolerance skills training

Who Is Running the Clinical Trial?

Rhode Island Hospital

Lead Sponsor

Trials

275

Recruited

71,400+

Brown University

Collaborator

Trials

480

Recruited

724,000+